Evidence indicates that genetic deletion or targeting of specific NOX isoforms to inhibit ROS production, along with enhancing antioxidant mechanisms such as SOD and catalase to promote ROS scavenging, may improve renal structure and function, lower BP, and ultimately prevent or alleviate the development of HTN and its complications. Here, SOD1 is linked to hypertensive disorder.